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Abstract. 
 
U2AF
 
65
 
 is an essential splicing factor that 
promotes binding of U2 small nuclear (sn)RNP at the 
pre-mRNA branchpoint. Here we describe a novel 
monoclonal antibody that reacts specifically with 
U2AF
 
65
 
. Using this antibody, we show that U2AF
 
65
 
 is 
diffusely distributed in the nucleoplasm with additional 
concentration in nuclear speckles, which represent sub-
nuclear compartments enriched in splicing snRNPs and 
other splicing factors. Furthermore, transient expres-
sion assays using epitope-tagged deletion mutants of 
U2AF
 
65
 
 indicate that targeting of the protein to nuclear 
speckles is not affected by removing either the RNA 
binding domain, the RS domain, or the region required 
for interaction with U2AF
 
35
 
. The association of 
U2AF
 
65
 
 with speckles persists during mitosis, when 
transcription and splicing are downregulated. More-
over, U2AF
 
65
 
 is localized to nuclear speckles in early 
G
 
1
 
 cells that were treated with transcription inhibitors 
during mitosis, suggesting that the localization of 
U2AF
 
65
 
 in speckles is independent of the presence of 
pre-mRNA in the nucleus, which is consistent with the 
idea that speckles represent storage sites for inactive 
splicing factors. After adenovirus infection, U2AF
 
65
 
 re-
distributes from the speckles and is prefferentially de-
tected at sites of viral transcription. By combining ade-
noviral infection with transient expression of deletion 
mutants, we show a specific requirement of the RS 
domain for recruitment of U2AF
 
65
 
 to sites of active 
splicing in the nucleus. This suggests that interactions 
involving the RS region of U2AF
 
65
 
 may play an impor-
tant role in targeting this protein to spliceosomes in 
vivo.
 
T
 
he
 
 splicing of intronic sequences from pre-mRNA
occurs within a multicomponent RNA–protein com-
plex called the spliceosome (for review see Moore
et al., 1993). The major subunits of the spliceosome are the
U1, U2, U4/U6, and U5 small nuclear (sn)
 
1
 
 RNPs (for re-
view see Baserga and Steitz, 1993). In addition, spliceo-
somes contain a group of non-snRNP protein splicing fac-
tors, several of which have been purified and cloned (for
review see Krämer, 1996). In mammalian cells, the best
characterized are U2AF (U2 snRNP auxiliary splicing fac-
tor), ASF/SF2 (alternative splicing factor/splicing factor
2), and SC-35 (35-kD spliceosomal component). Sequence
comparison revealed that these three factors have a com-
mon basic structure that can be divided into two functional
subdomains: a consensus type RNA binding domain and a
region of arginine/serine (RS) repeats. The RNA-binding
domain consists of one or more RNP consensus motifs
(RNP-CS) that are required for high affinity and se-
quence-specific binding of the proteins to RNA (Burd and
Dreyfuss, 1994). The RS motif consists of either an unin-
terrupted stretch of arginine/serine dipeptides or a more
dispersed RS-rich region (for review see Lamm and La-
mond, 1993). Interestingly, a single monoclonal antibody
reacts with a family of at least six RS-rich splicing proteins,
including ASF/SF2 and SC-35 (Zahler et al., 1992). The
members of this family are commonly referred to as SR
protein splicing factors and are highly conserved between
 
Drosophila
 
 and humans (Mayeda et al., 1992; Zahler et al.,
1992). These proteins have been shown to be required for
spliceosome assembly as well as for the first step of the
splicing reaction, and more recent evidence indicates that
they are also implicated in splice site selection and regu-
lated alternative splicing (Wu and Maniatis, 1993; Kohtz
et al., 1994).
U2AF is an essential splicing factor required for binding
of U2 snRNP to the pre-mRNA branch point (Ruskin et al.,
1988; Zamore and Green, 1989). It is composed of two
subunits, U2AF
 
65
 
 and U2AF
 
35
 
 (Zamore et al., 1992; Zhang
et al., 1992). While the 65-kD subunit alone is sufficient to
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Abbreviations used in this paper
 
: CS, consensus sequence; RS, arginine/
serine; sn, small nuclear.
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reconstitute the in vitro splicing activity of nuclear extracts
that have been depleted of U2AF by chromatography on
poly (U) Sepharose (Zamore and Green, 1991; Zamore et
al., 1992; Valcárcel et al., 1993, 1996), a requirement for
U2AF
 
35
 
 has been documented genetically (Rudner et al.,
1996) and biochemically using immunodepleted extracts
(Zuo and Maniatis, 1996). The RNA binding domain of
U2AF
 
65
 
 contains three RNP consensus sequence motifs
that specifically bind to the polypyrimidine tract adjacent
to the 3
 
9
 
 splice site (Zamore et al., 1992; Valcárcel et al.,
1993; Singh et al., 1995). The RS domain is located at the
NH
 
2
 
-terminus of the protein and promotes the annealing
of U2 snRNA to the pre-mRNA branchpoint (Valcárcel et
al., 1996).
Although much is known about the biochemical details
of splicing in vitro, the organization of RNA processing in
the cell nucleus is only starting to be understood. Localiza-
tion studies have shown that proteins involved in pre-
mRNA maturation tend to be heterogenously distributed
in the nucleus, suggesting that the processing reactions
might be compartmentalized in vivo (Carter et al., 1993).
Early electron microscopic studies have clearly established
that RNA–protein complexes in the nucleus are localized
to distinct types of structures, namely the nucleolus, the
perichromatin fibrils, the clusters of interchromatin gran-
ules, and the coiled body (for review see Monneron and
Bernhard, 1969). Electron microscopic autoradiography
has further demonstrated that extranucleolar RNA syn-
thesis occurs in association with perichromatin fibrils, and
the more recent techniques of immunoelectron micros-
copy have shown that several components of the pre-
mRNA splicing machinery are associated with perichro-
matin fibrils (for review see Fakan, 1994). Thus, it is likely
that these fibrils represent nascent transcripts with associ-
ated spliceosomes. At the light microscopic level it is not
possible to resolve perichromatin fibrils, and when immu-
nofluorescence is performed using antibodies that label
perichromatin fibrils (for example, antibodies to snRNP or
heterogeneous nuclear [hn]RNP proteins), the staining is
diffuse in the nucleus, excluding the nucleolus. As peri-
chromatin fibrils are present throughout the nucleoplasm,
it is conceivable that the diffuse fluorescent signal repre-
sents labeling associated with these fibrils. However, since
sn- and hnRNPs are very abundant nuclear components
(Rosbash and Singer, 1993; Kiledjian et al., 1994), it is also
possible that a pool of excess proteins contributes to the
diffuse labeling pattern observed.
In addition to the widespread nucleoplasmic distribu-
tion, fluorescence confocal microscopy has revealed that
several constituents of the spliceosome appear concen-
trated in nuclear “speckles” or “foci,” and at the electron
microscopic level these sites were shown to correspond to
clusters of interchromatin granules and coiled bodies, re-
spectively (for review see Spector, 1993). Studies from sev-
eral laboratories indicate that each of the spliceosomal
snRNPs is present widespread in distribution in the nucle-
oplasm, with an additional concentration in both clusters
of interchromatin granules and coiled bodies (for review
see Bohmann et al., 1995
 
a
 
), whereas SR protein splicing
factors are predominantly detected in speckles (i.e., clus-
ters of interchromatin granules; Fu and Maniatis, 1990;
Spector et al., 1991). In contrast, U2AF was described as
diffusely distributed in the nucleoplasm with additional
concentration in coiled bodies (Carmo-Fonseca et al.,
1991; Zamore and Green, 1991; Zhang et al., 1992). How-
ever, more recent evidence indicates that the RS domain
of the 
 
Drosophila
 
 splicing protein Tra contains a sequence
that can function both as a nuclear localization signal and
a speckle localization signal (Hedley et al., 1995). As a
similar amino acid sequence motif is found in the RS re-
gion of U2AF
 
65
 
, this protein should also localize to nuclear
speckles.
In this report we describe a novel monoclonal antibody
that specifically reacts with U2AF
 
65
 
, and we show that this
protein colocalizes with splicing snRNPs and SR protein
splicing factors in nuclear speckles. We also present evi-
dence that the association of U2AF
 
65
 
 with the nuclear
speckles is unrelated to splicing activity, consistent with
the idea that these structures represent a subnuclear com-
partment dedicated to storage or preassembly of the splic-
ing machinery. Finally, the data indicate that the RS domain
of U2AF
 
65
 
 is required for recruitment to active splicing
sites in vivo.
 
Materials and Methods
 
Production of mAbs
 
Eight female BALB/c mice were immunized with purified recombinant
U2AF
 
65
 
 expressed in 
 
Escherichia coli.
 
 The protein was diluted with PBS
to a concentration of 0.2 
 
m
 
g/ml, emulsified with Freund’s adjuvant (Difco
Laboratories, Detroit, Michigan), and injected intraperitonially. Mice
were boosted twice at 3 wk intervals, and test bleeds were taken. The sera
were screened by ELISA and immunobloting using recombinant U2AF
 
65
 
as antigen. The sera from all animals tested positive in these assays but
varied significantly in antibody titer. The spleen cells from the two mice
with higher antiserum titer were fused with Ag8.653 myeloma cells, and
hybrids were selected as described by Harlow and Lane (1988). After 10 d,
hybridoma supernatants were tested for reactivity with recombinant
U2AF
 
65
 
 by ELISA. Of 480 fusion wells, 3 tested positive and 2 (MC2 and
MC3) were successfully cloned by limiting dilution on microtiter plates.
The two hybridoma cell lines were used to induce a peritoneal tumor in
pristane primed adult female mice, and ascitic fluid was collected (Harlow
and Lane, 1988). The antibody subtypes were determined using a kit from
Boehringer Mannheim GmbH (Mannheim, Germany).
 
Immunobloting, Immunodepletion, and 
Complementation Assays
 
Total cell protein extracts were prepared by scraping the cells with a rub-
ber policeman into SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8,
2% SDS, 5% 
 
b
 
-mercaptoethanol, 10% glycerol, and 0.01% bromophenol
blue) with 200 U/ml benzonase (Sigma Chemical Co., St. Louis, MO), in-
cubating for 15 min at room temperature (to digest DNA), and then boil-
ing for 5 min. The SR protein extract was prepared as described by Zahler
et al. (1992). 
 
Drosophila
 
 and 
 
Xenopus
 
 protein extracts were prepared
from SL2 and MCM cells, respectively. Proteins were separated on either
8 or 12% acrylamide gels and transferred to nitrocellulose membranes us-
ing a semi-dry electrotransfer apparatus (BioRad Laboratories, Rich-
mond, California). The membranes were blocked and washed with 2%
nonfat milk powder in PBS. The blots were incubated for 1 h with hybri-
doma supernatant diluted in washing buffer, washed, and incubated for 1 h
with secondary antibody conjugated to alkaline phosphatase (BioRad
Laboratories).
Immunodepletion of nuclear extracts was performed as follows: 100 
 
m
 
l
of protein A–agarose beads (Sigma Chemical Co.) were washed twice
with 500 
 
m
 
l of buffer D (20 mM Hepes, pH 8.0, 0.2 mM EDTA, 20% glyc-
erol, 0.1M KCl, 1 mM DTT, 0.05% NP-40) on ice and incubated with 200 
 
m
 
l
of MC3 supernatant for 90 min at 4
 
8
 
C. After two washes in the same
buffer, the beads were added to 100 
 
m
 
l of nuclear extract (Dignam et al.,
1983) and incubated for 3 h at 4
 
8
 
C. The depleted extract was collected by 
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centrifugation. For the complementation assays, splicing reactions were
performed with 10 fmoles of an adeno major late promoter-derived pre-
mRNA substrate, 22% HeLa nuclear extract (either complete or MC3-
depleted), 3.3% polyvinyl alcohol, 1.67 mM MgCl
 
2
 
, 25 mM KCl, 1 mM
ATP, 22 mM creatine phosphate, in the presence or absence of 12.5 ng/
 
m
 
l
of recombinant purified GST-U2AF
 
65
 
 protein, for 2 h at 30
 
8
 
C. After pro-
teinase K, phenol extraction, and precipitation, the products of the splic-
ing reaction were analyzed by PAGE on a 13% gel.
 
Cell Culture, Drug Treatment, and Viral Infection
 
HeLa cells were grown as monolayers in Dulbecco’s modified minimum
essential medium supplemented with 10% fetal calf serum and maintained
mycoplasm free. Mitotic cells were isolated by the shake-off method, al-
lowed to sediment by gravity for 1 h on ice, plated on glass coverslips, and
further incubated at 37
 
8
 
C for 50–60 min to obtain a population enriched in
late telophase/early G
 
1
 
 cells. For inhibition of transcriptional activity, cells
were treated for 1 to 2 h with either 5 
 
m
 
g/ml actinomycin D (Sigma Chem-
ical Co.) or 75 
 
m
 
M DRB (5,6-dichloro-1-
 
b
 
-
 
d
 
-ribofuranosylbenzimidazole;
Sigma Chemical Co.). Reversal of the DRB transcription block was made
by washing the cells three times with fresh medium and allowing them to
recover for 1 h at 37
 
8
 
C. Infection of HeLa cells with adenovirus type 2
(Ad2) was performed as described (Pombo et al., 1994).
 
Transient Transfection Assays
 
The following primers were prepared. T8: 5
 
9
 
-CCGGTACCGACACCAT-
GTACGACTACGTCCCTGATTAG CAATGTCGGACTTCGAC-3
 
9
 
. T9:
5
 
9
 
-GGACGCGTCTACCAGAAGTCCCGGCGGTG-3
 
9
 
. T10: 5
 
9
 
-GGAC-
GCGTCTACTTGTGGGCAGAGTCGGG-3
 
9
 
. NLR1: 5
 
9
 
-CTCGTGGAG-
GGGGGAACGAATCAG-3
 
9
 
. RK36: 5
 
9
 
-CTCTACGTGGGCAACATC-
CCC-3
 
9
 
. RK38: 5
 
9
 
-CTGTTCA TCGGGGGCTTACCC-3
 
9
 
.
 
 
 
Primer T8 was
designed to encode a 10 amino acid hemagglutinin (HA) epitope tag to
distinguish the transiently expressed protein from the endogenous pro-
tein. Templates for PCR were as described by Zamore et al. (1992). HA-
tagged U2AF
 
65
 
WT and U2AF
 
65
 
D
 
RS cDNAs were prepared using primers
T8 and T9. U2AF
 
65
 
D
 
RNP2,3 was prepared using primers T8 and T10.
U2AF
 
65
 
D
 
84-150 and U2AF
 
65
 
D
 
84-260 were prepared using pECE-
U2AF
 
65
 
-T (Zamore et al., 1992) and primers NLR1/RK36 and NLR1/
RK38, respectively. PCR was carried out under the following conditions:
94
 
8
 
C for 30 s, 64
 
8
 
C for 30 s, and 72
 
8
 
C for 3 min. Upon completion of the 30
cycles, an additional elongation step was carried out for 7 min at 72
 
8
 
C. The
products and the expression vector CMV5 (see Andersson et al., 1989;
kindly provided by Dr. Maria Zapp, University of Massachusetts Medical
Center, Worcester, MA) were cut with KpnI and MluI for ligation. The li-
gated product was transformed into DH5
 
a
 
. DNA sequence analysis was
performed to determine if the clones contained the correct deletions.
DNA constructs were transiently transfected into cells, and Western blot
analysis was performed using anti-HA antibodies to determine if the con-
structs were being expressed (data not shown). Transient transfection of
HeLa cells was performed using Lipofectin (GIBCO BRL, Gaithers-
burg, MD), according to the manufacturer’s instructions. Approximately 2
 
m
 
g of DNA was used per assay. The cells were analyzed by immunofluo-
rescence at 24 to 48 h after transfection.
 
Immunofluorescence
 
For indirect immunofluorescence the cells were grown on 10 
 
3
 
 10-mm
glass coverslips and harvested at 60–80% confluency. Coverslips with at-
tached cells were washed twice in PBS and treated according to the fol-
lowing alternative protocols: (
 
a
 
) immediate fixation with 3.7% formalde-
hyde (freshly prepared from paraformaldehyde) in PBS for 10 min at
room temperature and subsequent permeabilization with 0.5% Triton
X-100 in PBS for 15 min at room temperature; (
 
b
 
) permeabilization with
0.5% Triton X-100 in CSK buffer (Fey et al., 1986) containing 0.1 mM
PMSF for 1 min on ice and subsequent fixation with 3.7% formaldehyde
in CSK for 10 min at room temperature. After fixation and permeabiliza-
tion, the cells were rinsed in PBS containing 0.05% Tween 20 (PBS-T), in-
cubated for 1 h with primary antibodies diluted in PBS-T, washed, and in-
cubated for 30 min with the appropriate secondary antibodies conjugated
to either fluorescein or Texas red (Dianova GmbH, Hamburg, Germany;
Vector Laboratories, Peterborough, UK). Finally, the coverslips were
mounted in VectaShield (Vector Laboratories) and sealed with nail polish.
In addition to the mAbs directed against U2AF
 
65
 
, the following anti-
bodies were used in this study: human autoantiserum C45, specific for Sm
 
proteins (kindly provided by Professor W. van Venrooij, University of
Nijmegen, The Netherlands), mAb 3C5 directed against SR proteins
(Turner and Franchi., 1987; Bridge et al., 1995), rabbit polyclonal serum
204.4 directed against the coiled body protein p80-coilin (Bohmann et al.,
1995
 
b
 
), rabbit polyclonal serum directed against the adenoviral protein
DBP (Linné et al., 1977), mAb 4B10 specific for hnRNP protein A1
(Piñol-Roma et al., 1988), and mAb 12CA5-I directed against the HA
epitope (Berkeley Antibody Company, Richmond, CA). Note that double
labeling with the mAbs 3C5 and MC3 was possible because 3C5 is an IgM
and MC3 is an IgG. To control the specificity of the secondary antibodies,
the cells were incubated with each primary antibody alone and then incu-
bated alternatively with either anti-IgM or anti-IgG conjugates.
In situ hybridization to detect poly A RNA was performed as described
(Carmo-Fonseca et al., 1992) using a biotinylated 2
 
9
 
-
 
O
 
-methyl oligoribo-
nucleotide probe (Sproat et al., 1989) containing 20 tandem uridine resi-
dues. Detection of adenoviral RNA was performed as described (Pombo
et al., 1994).
 
Fluorescence and Confocal Microscopy
 
Samples were examined with a microscope (LSM 410; Zeiss, Inc.,
Oberkochen, Germany). Confocal microscopy was performed using argon
ion (488 nm) and HeNe (543 nm) lasers to excite FITC and Texas red flu-
orescence, respectively. For double labeling experiments, images from the
same focal plane were sequentially recorded and superimposed. To obtain
a precise alignment of superimposed images the equipment was calibrated
using multicolor fluorescent beads (Molecular Probes Inc., Eugene, OR)
and a dual-band filter that allows simultaneous visualization of red and
green fluorescence. The images were photographed on Fujichrome 100 or
Kodak TMax 100 film, using a freeze frame recorder (Polaroid Corp.,
Cambridge, MA). Alternatively, data files were directly printed on a digi-
tal printer (XLS 8300; Kodak Co., Rochester, NY).
 
Results
 
Monoclonal Antibody MC3 Specifically
Recognizes U2AF
 
65
 
To obtain monoclonal antibodies, hybridomas were de-
rived by fusion of the mouse myeloma cell line Ag8.653
with spleen cells from BALB/c mice immunized with re-
combinant U2AF
 
65
 
. Two clones, MC2 and MC3, tested
positive by ELISA using purified recombinant U2AF
 
65
 
 as
antigen. The antibody secreted by the MC2 clone is of the
IgG
 
1
 
 class, and mAb MC3 is IgG
 
2b
 
. Immunoblot analysis
reveals that both mAbs recognize a single 
 
z
 
65-kD band in
HeLa protein extracts, that migrates with the same appar-
ent molecular weight as the recombinant U2AF
 
65
 
 protein
used for immunizations (Fig. 1 
 
A
 
, and data not shown).
Since the mAb MC3 reacts with U2AF
 
65
 
 with much higher
affinity than mAb MC2, it was chosen for further use.
Western blot analysis using a nuclear extract enriched in
SR proteins (Zahler et al., 1992) shows that mAb MC3
does not crossreact with the SR family of protein splicing
factors (Fig. 1 
 
A
 
). The mAb MC3 recognized a 
 
z
 
65-kD
protein from 
 
Xenopus
 
 but failed to react with 
 
Drosophila
 
protein extracts (results not shown).
As U2AF
 
65
 
 is an essential splicing factor, we tested mAb
MC3 for the ability to deplete splicing activity from nu-
clear extracts. Western blot analysis reveals that U2AF
 
65
 
 is
almost completely depleted from nuclear extracts incu-
bated with mAb MC3 bound to protein A–agarose beads
(Fig. 1 
 
B
 
; the immunodepletion efficiency ranged between
90 and 99%). The depleted extracts do not support in vitro
splicing reactions, but splicing activity can be successfully
recovered by the addition of recombinant U2AF
 
65
 
 (Fig.
1 
 
C
 
). Although the incubation of nuclear extracts with mAb
MC3 results in depletion of both U2AF
 
65
 
 and U2AF
 
35
 
 (re- 
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sults not shown), addition of U2AF
 
35
 
 is not required to re-
store splicing activity, as previously described (Zamore
and Green, 1991).
Using a series of GST-U2AF
 
65
 
 deletion mutants (Val-
cárcel et al., 1996), we conclude that the epitope recog-
nized by mAb MC3 maps between amino acids 138 and
161 (Fig. 2).
 
Subnuclear Localization of U2AF
 
65
 
Indirect immunofluorescence was performed using mAbs
MC2 and MC3. Both antibodies produced a diffuse stain-
ing of the nucleoplasm excluding the nucleoli, with addi-
tional concentration in 20–50 speckles (Fig. 3 
 
A
 
). These re-
sults were obtained in HeLa and Hep-2 cells as well as in
cryosections from rat brain tissue (data not shown). Simi-
lar results were observed when cultured cells were treated
with Triton X-100 either before or after fixation with
formaldehyde or when the antibody was directly microin-
jected into the nuclei of living cells (Fig. 3 
 
D
 
). Double la-
beling experiments were performed using the mAb MC3
and either an anti-Sm antibody, which reacts with all splic-
ing snRNPs (Baserga and Steitz, 1993), mAb 3C5, which
recognizes SR protein splicing factors (Bridge et al., 1995)
and labels clusters of interchromatin granules by immuno-
electron microscopy (Turner and Franchi, 1987), or an
anti-coilin antibody to label coiled bodies (Bohmann et al.,
1995
 
b
 
). The results show that U2AF
 
65
 
 colocalizes with sn-
RNPs and SR proteins in nuclear speckles (Fig. 3, B and C,
and data not shown), but labeling of coiled bodies was
never detected (Fig. 3, D and E, and data not shown). This
contrasts with the results previously obtained using a puri-
fied polyclonal antibody raised against a synthetic peptide
of U2AF65, which produced a predominantly diffuse nucleo-
plasmic staining with additional concentration in coiled bod-
ies (Carmo-Fonseca et al., 1991; Zamore and Green,
1991). In this regard it is noteworthy that when the mAb
MC3 is used at high dilutions it also produces a predomi-
nantly diffuse staining pattern. This argues that the failure
to detect speckles previously could have been due to a low
titer of the anti-peptide antibody. Furthermore, when cells
are treated with actinomycin D for 1–2 h, U2AF65 is de-
tected both in enlarged speckles and in perinucleolar
patches (Fig. 3 F, arrowheads, and G). As a similar perinu-
cleolar staining was previously observed (Carmo-Fonseca
et al., 1991), this suggests that in vivo the antipeptide anti-
body reacts preferentially with a subfraction of the total
U2AF65 in the nucleus. In contrast, the reason for the dif-
ferential recognition of coiled body epitopes in vivo by
these two antibodies remains to be elucidated. Clearly,
there are peculiar properties of the epitopes recognized by
the distinct antibodies, and to solve this discrepancy we
have analyzed the distribution of epitope-tagged U2AF65
in transiently transfected HeLa cells. The results observed
are identical to those revealed by the new monoclonal an-
tibodies (Figs. 3 A and 8 A), allowing us to settle the con-
troversy.
U2AF65 Associates with Interchromatin Granules 
during Mitosis
To investigate whether the presence of U2AF65 in nuclear
speckles is associated with splicing, we studied the distri-
bution of U2AF65 during mitosis, when transcription and
hence splicing activities are inhibited (Prescott and Bender,
1962). From metaphase through telophase the mAb MC3
produces a diffuse staining of the cell excluding the chro-
mosomes, with additional concentration in speckled struc-
Figure 1. The mAb MC3 reacts specifically with U2AF65. (A) Im-
munoblot analysis was performed using MC3 hybridoma super-
natant diluted 1:100. A 12% acrylamide gel was loaded with total
protein extract from HeLa cells (1–4 3 105 cells/well), SR pro-
tein-enriched fraction (10 mg/well), and purified recombinant
U2AF65 (0.2 mg/well). Molecular weight markers are indicated on
the left. (B) Immunoblot analysis of nuclear extracts (1, 2, or 5 ml
per lane, as indicated). NE, control nuclear extract; DNE, nuclear
extract immunodepleted using mAb MC3. (C) In vitro reconsti-
tution/splicing reactions were performed using nuclear extract
(control), U2AF65-immunodepleted extract (DNE), or U2AF65-
immunodepleted extract plus 12.5 ng/ml of purified recombinant
U2AF65 (rNE).
Figure 2. Epitope mapping of U2AF65. (A) Diagram showing the
reactivity of mAb MC3 with different GST–U2AF65 fusion pro-
teins as determined by immunoblot analysis. The grey bars repre-
sent the U2AF65 fragment fused to the GST protein. Hatched re-
gions represent internal deletions of U2AF65. (B) Diagram
showing the mapped epitope (amino acids 138–161, bar) in rela-
tion to the functional organization of U2AF65. The mapped re-
gion overlaps with the beginning of the RNA binding domain
(amino acids 151–462).Gama-Carvalho et al. Subnuclear Localization of U2AF65 979
tures (Fig. 4, A–C). Double labeling experiments using the
mAb MC3 and anti-Sm antibody (Fig. 4, D–L) or the mAb
3C5 (data not shown) indicate that U2AF65 colocalizes
with snRNPs and SR proteins in mitotic speckles that cor-
respond to mitotic clusters of interchromatin granules
(MIGs; Ferreira et al., 1994). In contrast, a colocalization
of U2AF65 with mitotic coiled bodies was never detected.
The association of U2AF65 with mitotic speckles is most
prominent during telophase, when the number and size of
MIGs is higher (Ferreira et al., 1994). In late telophase/
early G1 cells, U2AF65 and snRNPs are predominantly de-
tected within the nuclei of daughter cells, whereas the
mAb 3C5 labels large speckles that persist in the cyto-
plasm (Fig. 4, M–O). This suggests that at the end of mito-
sis, U2AF65 and snRNPs leave the MIGs and are rapidly
transported into the daughter cell nuclei, whereas SR pro-
teins remain associated with MIGs in the cytoplasm for a
longer period of time.
U2AF65 Associates with Speckles in the Absence of 
Nuclear poly (A) RNA Synthesis
Having established that U2AF65 associates with interchro-
matin granules during mitosis when there is no transcrip-
tional activity, we next asked whether U2AF65 can be tar-
geted to nuclear speckles in the absence of poly (A) RNA
synthesis. Mitotic HeLa cells were treated with either 5
mg/ml actinomycin D or 75 mM DRB for 1 h to inhibit
transcriptional activity, and immunofluorescence was per-
formed using the mAb MC3. In all early G1 cells observed,
the staining was concentrated in nuclear speckles, and
double labeling experiments using anti-Sm antibodies in-
dicate that inhibition of transcription does not affect the
targeting of either U2AF65 or snRNPs to nuclear speckles
(Fig. 5, A–C). A parallel labeling of the cells with a mAb
for hnRNP A1 confirmed the efficiency of the transcrip-
tion block, since transport of this protein into the nucleus
at the end of mitosis is transcription dependent (Piñol-
Roma and Dreyfuss, 1991). In addition, in situ hybridiza-
tion experiments using a poly (U) oligonucleotide probe
fail to detect any poly (A) RNA signal in the nuclei of
early G1 cells treated with transcription inhibitors during
mitosis (Fig. 5, D–F). Taken together, these data suggest
that the localization of U2AF65 to nuclear speckles is unre-
lated to splicing activity.
The RS Region of U2AF65 Is Not Required for 
Targeting to Nuclear Speckles
Recently, Hedley et al. (1995) identified an amino acid se-
quence within the RS region of the Drosophila protein Tra
that is sufficient to target an heterologous protein to nu-
clear speckles. Since a similar sequence motif (i.e., a stretch
of basic amino acids followed by RS dipeptides and a puta-
tive bipartite NLS) is present in the RS region of U2AF65
(Fig. 6 A), we decided to study the role of the U2AF65 RS
Figure 3. Subnuclear localization of U2AF65. (A) HeLa cells
were fixed with formaldehyde, permeabilized with Triton X-100,
and incubated with mAb MC3 (hybridoma supernatant undi-
luted). (B and C) HeLa cells were permeabilized with Triton
X-100 before fixation. Double labeling was then performed using
mAb MC3 (B) and mAb 3C5 (C). (D and E) Living HeLa cells
were microinjected in the nucleus with MC3 ascitic fluid and fur-
ther incubated at 378C for 30 min. Then, the cells were fixed in
formaldehyde, permeabilized with Triton X-100, and sequentially
incubated with anti-coilin rabbit polyclonal antibody, anti–rabbit
IgG coupled to Texas red (E), and anti–mouse IgG coupled to
FITC (D). In D, arrowheads indicate the position of coiled bod-
ies as observed on overlays of both fluorescence signals. The cells
depicted in panels F and G were incubated with 5 mg/ml actino-
mycin D for 2 h, permeabilized with Triton X-100, fixed in form-
aldehyde, and double labeled with MC3 (F) and anti-Sm antibod-
ies (G). Arrowheads in F indicate staining of perinucleolar
structures. Bars, 10 mm.The Journal of Cell Biology, Volume 137, 1997 980
region in subnuclear localization. Transient transfection
assays were performed on HeLa cells using the pCMV5
expression vector (Andersson et al., 1989). The vector con-
tained a 10 amino acid influenza HA epitope tag cloned
in frame in front of the cDNA coding for U2AF65. Four
deletion mutants were analyzed: U2AF65DRS-T has a de-
letion of amino acids 23–65, covering all the RS domain;
U2AF65DRNP2,3-T has a deletion of amino acids 260–475,
spanning the RNA binding regions RNP2 and RNP3;
U2AF65D84-150-T has a deletion of amino acids 84–150,
Figure 4. Intracellular distribution of
U2AF65 during mitosis. HeLa cells were
fixed with formaldehyde, permeabilized
with Triton X-100, and incubated with
mAb MC3 (A–C) or double-labeled with
mAb MC3 and anti-Sm antibody (D–L).
From metaphase to telophase, the stain-
ing produced by mAb MC3 is diffuse in
the cytoplasm, excluding the chromo-
somes, with additional concentration in
speckles (A–C, arrowheads). During the
early stages of telophase, both U2AF
and snRNPs colocalize in mitotic speck-
les and are excluded from the newly
forming nucleus (D–F). As telophase
proceeds, U2AF and snRNPs are simul-
taneously detected in mitotic speckles
(arrowheads) and within the daughter
cell nuclei (G–I), whereas in early G1
cells, U2AF and snRNPs are exclusively
detected in the nucleus (J–L). For dou-
ble labeling experiments using mAbs
MC3 and 3C5, the cells were extracted
with Triton X-100 before formaldehyde
fixation (M–O). These experiments
show that in late telophase cells, SR pro-
teins persist associated with mitotic
speckles (N, arrowheads), while U2AF is
predominantly localized to the nucleus
(M). Inspection of cells at earlier stages
of telophase confirm the presence of
U2AF in mitotic speckles in these prepa-
rations, indicating that this lack of colo-
calization between U2AF and SR pro-
teins is not an artifact induced by the
preextraction procedure. Bar, 10 mm.Gama-Carvalho et al. Subnuclear Localization of U2AF65 981
covering the region of interaction with U2AF35; and
U2AF65D84-260-T has a deletion of amino acids 84–260
spanning both the region of interaction with U2AF35 and
the RNP1 domain (Fig. 6 B).
The mAb 12CA5, which is specific for the HA tag, pro-
duces a faint background staining on untransfected HeLa
cells or on cells transfected with the vector alone (data not
shown). When cells are transfected with either epitope-
tagged recombinant U2AF65 (U2AF65WT-T) or either of the
deletion mutants, the mAb 12CA5 displays an intense
staining of the nucleus (Fig. 7). At higher magnification the
nuclear staining pattern is clearly speckled, similar to that
observed with mAb MC3 (Figs. 3 A and 8 A). Double la-
beling of the transfected cells with mAb 12CA5 and anti-Sm
antibodies show that U2AF65WT-T colocalizes with splic-
ing snRNPs in nuclear speckles but not in coiled bodies
(Fig. 8, A and E, and data not shown). Interestingly, the
deletion mutants U2AF65DRS-T, U2AF65DRNP2,3-T,
U2AF65D84-150-T, and U2AF65D84-260-T retained the abil-
ity to localize to nuclear speckles (Fig. 8, B and F, C and
G, D and H, and data not shown). Thus, neither of these
domains of U2AF65 on its own is essential to target the
protein to nuclear speckles.
The RS Region of U2AF65 Is Involved in Recruitment to 
Splicing Sites
Since the presence of U2AF65 in nuclear speckles appears
to be unrelated to splicing activity, we tried to visualize the
recruitment of this protein to active splicing sites within
the nucleus. For this we have made use of adenovirus in-
fection, because this virus subverts the normal nuclear or-
ganization by recruiting the host transcription and pro-
cessing machinery to the sites of viral mRNA synthesis
Figure 5. U2AF 65 associates
with nuclear speckles in the
absence of RNA synthesis.
Mitotic HeLa cells were
treated with 5 mg/ml actino-
mycin D for 1 h, and then
double immunofluorescence
was performed using mAb
MC3 and anti-Sm antibody.
The labeling produced by
both antibodies is clearly
concentrated in nuclear
speckles (A–C). A similar ex-
periment was performed
with the transcription inhibi-
tor DRB; then, the cells were
hybridized in situ with a poly
(U) riboprobe and immuno-
labeled with anti-Sm anti-
body. No poly (A) RNA is
detected in the nucleus,
while snRNPs are clearly
concentrated in nuclear
speckles (D–F). Bar, 10 mm.
Figure 6. Both U2AF65 and U2AF35 contain putative “speckle lo-
calization signals.” (A) Diagram showing the putative speckle lo-
calization signal of the Drosophila melanogaster splicing factor
Tra, identified by Hedley et al. (1995) and similar sequence mo-
tifs present in U2AF65 and U2AF35 that may represent potential
nuclear and subnuclear localization signals. Shown is the amino
acid sequence of the SR domain of both proteins. Sequences con-
taining three or four basic residues directly adjacent to RS dipep-
tides are boxed. Putative nucleoplasmin-like NLSs are indicated.
(B) A diagram of the constructs used for transfection is shown:
, HA-tag; 35, binding region for U2AF35.The Journal of Cell Biology, Volume 137, 1997 982
(Jiménez-Garcia and Spector, 1993; Pombo et al., 1994).
When adenovirus-infected HeLa cells are probed with
mAb MC3, the nuclear staining pattern changes signifi-
cantly depending on the stage of infection. During the
early phase of infection (i.e., before the onset of major vi-
ral DNA replication, which occurs at z8 h after infection),
U2AF65 is detected in speckles, similar to that observed in
noninfected cells (data not shown). After the onset of viral
replication the normal nuclear architecture is grossly
changed, and U2AF65 is no longer observed in speckles.
Rather, in cells infected for 14–18 h the U2AF65 staining is
predominantly detected in ring-like structures that sur-
round the sites of viral DNA labeled with an antibody di-
rected against the adenovirus DNA binding protein, DBP.
As we had previously shown that adenovirus induces a re-
distribution of splicing snRNPs into ring-like structures
that colocalize with the sites of viral transcription (Pombo
et al., 1994), double labeling experiments were performed
using mAb MC3 and anti-Sm antibodies. The results in-
dicate that U2AF65 colocalizes with snRNPs in the ring-
like structures (Fig. 9, A–D), and similar results are ob-
served on cells that were sequentially transfected with
U2AF65WT-T, infected with adenovirus, and probed with
anti-tag antibody (Fig. 9, E and F). Thus, we conclude that
the ring structures labeled by MC3 and anti-tag antibody
correspond to U2AF65 at sites of active splicing. At later
stages of infection (20–24 h after infection), the ring-like
structures become less prominent, and U2AF65 is predom-
Figure 7. Epitope-tagged recombinant U2AF is targeted to the
nucleus. HeLa cells were transfected with the pCMV5 expression
vector containing a 10-amino acid influenza HA epitope tag
cloned in frame in front of the cDNA coding for either U2AF65
(A), U2AF65DRNP2,3 (B), U2AF65DRS (C), or U2AF65D84-150
(D). At 24 to 36 h after transfection the cells were fixed with
formaldehyde and permeabilized with Triton X-100, and the ec-
topically expressed protein was detected using mAb 12CA5 di-
rected against the HA tag. Bars, 10 mm.
Figure 8. Epitope-tagged recombinant U2AF is targeted to nuclear speckles. HeLa cells were transfected with either U2AF65-T (A and
E), U2AF65DRNP2,3-T (B and F), U2AF65DRS-T (C and G), or U2AF65D84-150-T (D and H). Cells were fixed at 24 to 36 h after trans-
fection, and the ectopically expressed protein was detected using mAb 12CA5 directed against the HA tag. Double labeling experi-
ments were performed using mAb 12CA5 (A–D) and anti-Sm antibody (E–H). An arrow in G indicates a coiled body that is stained by
anti-Sm antibody but not by mAb 12CA5. Cells depicted in A–C and E–G were permeabilized with Triton X-100 before fixation,
whereas the cells depicted in D and H were first fixed with formaldehyde and then permeabilized with Triton X-100. Extraction with de-
tergent before fixation significantly enhanced the speckled staining pattern. To ensure that U2AF was also detected in speckles when
cells were first fixed and then extracted with detergent, some samples were treated with actinomycin D for 1 h before fixation (D and
H). As previously demonstrated for other splicing factors, actinomycin D induces an accumulation of U2AF65 in enlarged, rounded up
speckles. Bar, 10 mm.Gama-Carvalho et al. Subnuclear Localization of U2AF65 983
inantly observed in enlarged speckles that also contain
splicing snRNPs, SR protein splicing factors, and viral
RNA (data not shown; see Bridge et al., 1996).
Consistent with the idea that upon viral infection,
U2AF65 is recruited from the nuclear speckles to ring-like
structures that represent sites of active viral RNA tran-
scription and processing, treatment of cells infected with
adenovirus for 14–16 h with transcription inhibitors such
as actinomycin D or DRB induces a relocalization of
U2AF65 into speckles (Fig. 10, A and D, B and E). After
removal of DRB, U2AF65 is again detected in ring-like
structures associated with the viral genomes (Fig. 10, C
and F), similar to the pattern observed in untreated cells
(Figs. 10 C and 9, B and F).
To test whether any of the major functional domains of
U2AF65 is required for targeting the protein to viral splic-
ing sites, HeLa cells were transfected with either
U2AF65DRS-T, U2AF65DRNP2,3-T, U2AF65D84-150-T, or
U2AF65D84-260-T and then infected with adenovirus (Fig.
11). The ectopically expressed proteins were detected us-
Figure 10. U2AF65 relocal-
izes to speckles upon inhibi-
tion of adenoviral transcrip-
tion. HeLa cells were
transiently transfected with
HA-tagged U2AF65 for 24 h
and then infected with Ad2.
At 14 h after infection the
cells were treated with either
5  mg/ml actinomycin D (A
and  D) or 75 mM DRB for 1 h
(B and E). After DRB treat-
ment, the drug was removed
from the culture medium,
and the cells were allowed to
recover for 1 h (C and F). A–C
depict U2AF65 labeling us-
ing an anti-tag antibody
(mAb 12C5), and panels D–F
depict the sites of viral ge-
nome accumulation using an
antibody directed against
the viral DNA binding pro-
tein DBP. Arrowheads point
to the localization of viral
centers. Bar, 10 mm.
Figure 9. Adenovirus induces a redistribution of U2AF65 in the
nucleus of infected cells. HeLa cells were either mock infected
(A, C, and E) or infected with Ad2 for 18 h, at a multiplicity of in-
fection of 20 focus forming units per cell (B, D, and F). The cells
were permeabilized with Triton X-100, fixed with formaldehyde,
and double labeled using mAb MC3 and anti-Sm antibody (A
and C, B and D). Alternatively, cells were first transfected with
U2AF65WT-T and then were either mock infected or infected
with Ad2 (E and F). The ectopically expressed protein was de-
tected using mAb 12CA5. Note that in uninfected cells, all anti-
bodies produce a speckled staining of the nucleoplasm (A, C, and
E), whereas after infection the staining is concentrated in ring-
like structures (B, D, and F). Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 984
ing the anti-tag mAb 12CA5, and the viral genomes were
visualized using a polyclonal antibody specific for the DBP
as previously described (Pombo et al., 1994). The results
confirm that U2AF65WT-T concentrates around the sites
of viral genome accumulation (Fig. 11, A and D). Unex-
pectedly, the deletion mutant U2AF65DRNP2,3-T, which
does not bind to pre-mRNA in vitro (Zamore et al., 1992),
is also redistributed to the sites of viral genome accumula-
tion and transcription (Fig. 11, B and E), indicating that
binding of U2AF65 to pre-mRNA is not essential to recruit
the protein to splicing sites in vivo, and similar results were
observed with U2AF65D84-150-T (Fig. 11, C and F) and
U2AF65D84-260-T (data not shown). In contrast, the dele-
tion mutant U2AF65DRS-T fails to concentrate in the typi-
cal ringstructures (Fig. 11, G and J). As the U2AF65 RS re-
gion is essential for splicing (Zamore et al., 1992; Valcárcel
et al., 1996), expression of the U2AF65DRS-T construct
could exert a dominant negative effect and therefore in-
hibit splicing in these cells. Consequently, the absence of
ring structures could reflect a block in splicing activity. To
address this point, cells were transfected with U2AF65DRS-T,
infected with adenovirus, and double labeled with anti-tag
and anti-Sm antibodies (Fig. 11, H and K). As depicted in
Fig. 11 K, Sm proteins are localized in ring structures, indi-
cating that expression of the U2AF65DRS-T construct does
not prevent recruitment of splicing snRNPs to the sites of
viral RNA synthesis. Furthermore, cells that express the
U2AF65DRS-T construct are shown to contain spliced viral
RNA in both the nucleus and the cytoplasm (Fig. 11, I and
L, and data not shown). This implies that normal process-
ing/transport of adenoviral RNA is taking place in these
cells.
In conclusion, the data suggest that the RS domain of
U2AF65 may play an important role in targeting the pro-
tein to sites of active transcription and splicing in vivo.
Discussion
In this study we show that a novel monoclonal antibody
specific for the splicing factor U2AF65 produces a diffuse
staining throughout the nucleoplasm with additional con-
centration in nuclear speckles, and a similar distribution
Figure 11. Recruitment of
U2AF65 to adenoviral splic-
ing sites. HeLa cells were
transiently transfected with
either U2AF65WT-T (A and
D), U2AF65DRNP2,3-T (B
and  E), U2AF65D84-150-T (C
and  F), or U2AF65DRS-T
(G–L) for 24–48 h and then
infected with Ad2 and har-
vested at 18 h after infection.
The cells were permeabilized
with Triton X-100, fixed with
formaldehyde, and double la-
beled using mAb 12C5 (A–C
and G) and a rabbit polyclonal
antibody directed against
the viral DNA binding pro-
tein DBP (D–F and J). Alter-
natively, the cells were dou-
ble labeled with mAb 12C5
and anti-Sm antibody (H and
K). The cells depicted in I
and  L were labeled with
mAb 12C5, digested with
DNaseI, and hybridized
with an Ad2 genomic probe
to detect viral RNA as previ-
ously described (Pombo et
al., 1994). Note that cells ex-
pressing U2AF65DRS contain
viral RNA in both the nu-
cleus and the cytoplasm (ar-
rowheads); the arrow indi-
cates a nontransfected cell.
Similar results were observed
in cells hybridized with a splice
junction oligonucleotide probe
(Bridge et al., 1996) to detect
spliced Ad2 RNA (not
shown). Bars, 10 mm.Gama-Carvalho et al. Subnuclear Localization of U2AF65 985
pattern is observed in cells transiently transfected with
epitope-tagged recombinant U2AF65. This makes it likely
that U2AF65 is localized to nuclear speckles.
Within the nucleus, U2AF65 is shown to colocalize with
splicing snRNPs and SR protein splicing factors in speck-
les that correspond to clusters of interchromatin granules
at the electron microscopic level. Since these clusters also
contain poly (A) RNA (Carter et al., 1991; Visa et al., 1993),
the presence of splicing factors in these structures has
been thought to represent a subnuclear compartmentaliza-
tion of spliceosomes assembled on pre-mRNA (Carter et al.,
1993). However, the findings that splicing occurs co-tran-
scriptionally (Beyer and Osheim, 1988; LeMaire and Thum-
mel, 1990; Bauren and Wieslander, 1994) and that there is
no transcriptional activity in clusters of interchromatin
granules (Fakan, 1994) argue against the idea that speckles
represent splicing sites. Alternatively, clusters of inter-
chromatin granules may be implicated in storage or preas-
sembly of the splicing machinery (Spector, 1993; Zhang
et al., 1994). Here we present further evidence consistent
with this view. First, U2AF65 is concentrated in interchro-
matin granules during mitosis when transcription and
splicing are downregulated. Second, at the end of mitosis,
U2AF65 is targeted to clusters of interchromatin granules
in the absence of newly synthesised poly (A) RNA in the
nucleus. Finally, the deletion mutant U2AF65DRS, which
fails to be recruited to active splicing sites, maintains the
ability to localize in nuclear speckles.
Although U2AF65 colocalizes with SR protein splicing
factors in nuclear speckles, there are some differences in
the subnuclear distribution of these two types of proteins.
First, during interphase, U2AF65 is clearly widespread in
the nucleoplasm with additional concentration in speckles,
whereas SR proteins are predominantly detected in speck-
les. Second, at the end of mitosis, U2AF65 is rapidly im-
ported into the daughter cell nuclei, while SR proteins re-
main concentrated in large cytoplasmic speckles for a
longer period of time. Thus, the intracellular dynamics of
U2AF65 appear to be more similar to snRNPs than to SR
proteins, and this discrepancy may be related to the struc-
tural and functional differences between U2AF65 and SR
proteins. In fact, U2AF65 binds to the polypyrimidine tract
of pre-mRNA and promotes binding of U2 snRNP to the
branchpoint (Ruskin et al., 1988; Zamore and Green, 1989),
whereas SR protein splicing factors are implicated in 59
and 39 splice site selection (Fu and Maniatis, 1992; Zahler
et al., 1992; Wu and Maniatis, 1993). Particularly, the RS
region of U2AF65 promotes a base-pairing interaction be-
tween U2 snRNA and the pre-mRNA (Valcárcel et al.,
1996), while the RS domains of SR protein splicing factors
mediate protein–protein interactions in the spliceosome
(Wu and Maniatis, 1993; Amrein et al., 1994; Kohtz et al.,
1994).
In addition to U2AF65, U2AF35, and SR protein splicing
factors, RS domains are also present in other proteins in-
volved in splicing. These include the U1 snRNP 70-kD
protein and the Drosophila splicing regulators suppressor
of white–apricot, Transformer (Tra), and Transformer 2
(Tra 2). Significantly, all of these proteins localize to nu-
clear speckles in mammalian cells (Verheijen et al., 1986;
Li and Bingham, 1991; Hedley et al., 1995), and recent evi-
dence indicates that an amino acid sequence within the RS
domain of the Drosophila Tra protein is sufficient for tar-
geting an heterologous protein to nuclear speckles (Li and
Bingham, 1991; Hedley et al., 1995). Like Tra, U2AF65 con-
tains an RS domain with a stretch of basic amino acids fol-
lowed by RS dipeptides and a putative bipartite NLS (Fig.
6 A), and we show here that it is also present in nuclear
speckles. However, our results further indicate that the in-
tranuclear distribution of the protein is not affected by de-
letion of the RS domain. In this regard, it is important to
note that a Tra deletion mutant lacking the “speckle local-
ization signal” has also been shown to localize to speckles,
presumably through interactions with another protein
(Tra 2) that contains the signal (Hedley et al., 1995). Thus,
it is conceivable that protein–protein interactions may
be responsible for targeting the U2AF65DRS mutant to the
speckles, and a potential candidate is U2AF35. In fact,
the RS domain of U2AF35 may also contain a putative
“speckle localization signal” (Fig. 6 A), and it binds to a
region of U2AF65 that is conserved in U2AF65DRS. Inter-
estingly, deletion of the U2AF65 region that interacts with
U2AF35 also does not affect targeting to the speckles, indi-
cating that this part of the protein is not essential for the
subnuclear localization of U2AF65. However, it remains
possible that either the presence of an RS domain in the
protein or interaction with U2AF35 may be sufficient to
target U2AF65 to the speckles, and further mutagenesis
work is currently in progress to address this question.
Also, more immunolocalization studies are necessary to
clarify the subnuclear distribution of U2AF35 since previ-
ous reports have failed to detect this protein in speckles
(Zhang et al., 1992).
In addition to the repeating RS dipeptides and a stretch
of basic amino acids, the RS region of U2AF65 contains a
potential nuclear localization signal (Fig. 6), and therefore
one might expect that the deletion mutant U2AF65DRS
would not be transported into the nucleus. Our observa-
tion that this mutant is present in the nucleus and localizes
to speckles raises the possibility that protein–protein inter-
actions may play an important role in both nuclear and
subnuclear localization of U2AF, as recently pointed out
by Hedley et al. (1995) for other splicing proteins.
Previous studies have demonstrated that adenovirus
subverts the normal organization of splicing factors in the
mammalian cell nucleus, although different patterns of
distribution have been described depending on the infec-
tion stage. When infected cells are treated with a DNA
synthesis inhibitor to block viral replication (Zhang et al.,
1994) or in cells analyzed at an early stage of infection
(Gama-Carvalho, M., R.D. Krauss, L. Chiang, J. Valcár-
cel, M.R. Green, and M. Carmo-Fonseca, unpublished re-
sults), splicing snRNPs are localized in nuclear speckles
that do not associate with sites of viral transcription and
splicing. After the onset of viral replication, at 14–18 h af-
ter infection, snRNPs redistribute from the speckles to
ring-like structures located at the periphery of the viral ge-
nomes and which have been shown to correspond to sites
of viral RNA synthesis (Pombo et al., 1994). At later stages
of infection (20–24 h after infection), snRNPs and splicing
factors are predominantly detected in large speckles that
contain spliced adenoviral RNA and represent enlarged
clusters of interchromatin granules (Bridge et al., 1993,
1995, 1996; Puvion-Dutilleul et al., 1994). Here we haveThe Journal of Cell Biology, Volume 137, 1997 986
analyzed cells at intermediate stages of adenoviral infec-
tion when sites of active viral transcription and splicing
can be easily identified as ring structures, and we show
that U2AF65 colocalizes with splicing snRNPs in these
structures. Furthermore, upon treatment of infected cells
with transcription inhibitors, U2AF65 was predominantly
detected in speckles and not in ring structures, whereas af-
ter release of the drug, U2AF65 was again detected in rings
and not in speckles. This suggests that at intermediate
stages of infection adenovirus induces a recruitment of
U2AF65 from the nuclear speckles to sites of active splic-
ing, and we have made use of this model system to test
whether deletion mutations that render U2AF65 unable to
support splicing in vitro also affect recruitment to splice-
osomes in vivo. The results show that the U2AF65DRNP2,3
deletion mutant, which does not bind to pre-mRNA in
vitro (Zamore et al., 1992), the U2AF65D84-150 mutant,
which has a deletion covering the region of interaction
with U2AF35, and U2AF65D84-260, which has a deletion
spanning both the region of interaction with U2AF35 and
the RNP1 domain, are all recruited to the sites of viral
splicing. In contrast, the U2AF65DRS mutant fails to con-
centrate in the ring structures that represent the sites of
adenoviral RNA synthesis. This raises the possibility that
in vivo the RS region of U2AF65 may be implicated in in-
teractions that are sufficient to recruit the protein to sites
of active transcription and splicing, even in the absence of
RNA binding capacity.
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